NON-SMALL CELL LUNG CARCINOMA

This study tests a vaccine made from lung cancer cells, combined with an immune-boosting drug (N-803), to see if it can prevent non-small cell lung cancer from returning after surgery. About 30 adults with no signs of cancer after surgery will receive the vaccine as shots under t…

This early-stage study tests a new cancer vaccine (p53MVA) combined with the immunotherapy drug pembrolizumab in people with advanced solid tumors that have not responded to other treatments. The vaccine helps the immune system recognize and attack cancer cells, while pembrolizum…

This program gives patients with serious non-small cell lung cancer access to the drug capmatinib when no other treatments are available and they cannot join a clinical trial. It is for people whose doctors have requested the drug and who have no satisfactory alternative therapy.…

This study tests whether adding high-dose vitamin C (ascorbate) to the usual treatment of radiation and chemotherapy (carboplatin and paclitaxel) helps control non-small cell lung cancer. About 43 participants received this combination therapy. The goal is to see if the vitamin C…

This early-stage study tests a combination of two drugs—trastuzumab deruxtecan and pembrolizumab—in people with advanced breast or non-small cell lung cancer that has spread. The goal is to find the best dose and see how well the combo shrinks tumors. About 115 adults with HER2-p…

This study tests an experimental drug called AZD2936 in people with advanced or metastatic non-small cell lung cancer (NSCLC) that has not responded to other treatments. The drug is a bispecific antibody designed to block two proteins (TIGIT and PD-1) that help cancer hide from t…

This study is for people with advanced solid tumors (like lung or colorectal cancer) that have a specific genetic change called KRAS G12C. It tests a new drug, JDQ443, combined with other treatments to see if they are safe and can shrink tumors. About 74 adults will take part. Th…

This study tests an online program designed to improve social well-being and emotional support for women being treated for lung cancer. About 70 women with stage I to IV non-small cell lung cancer will take part. The program uses mindfulness and emotional processing techniques to…

This study tests whether adding acupuncture to standard immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer live longer without their disease getting worse. About 60 participants will receive either real or sham acupuncture alongside their firs…

This study collects blood samples from 102 people with non-small cell lung cancer, colorectal cancer, or pancreatic cancer to track genetic changes in tumor DNA over time. Participants continue their standard treatments while researchers measure how cancer DNA levels in the blood…